Huge amounts of the hypertension drug Valsartan, the generic equivalent of the hypertension drug Diovan, were contaminated with a carcinogen called NDMA. In the wake of the Valsartan contamination and ensuing drug recall, lawsuits were filed across the United States on behalf of patients who purchased the unsafe contaminated drug, including for fraud and violation of warranties as well as other laws relating to the safe sale and distribution of prescription drugs. Valsartan is sold in the U.S. by three companies, Teva, Major Pharmaceuticals, and Solco Healthcare, and all of the blood drug that was recalled was manufactured by the Zhejiang Huahai Pharmaceutical Co. Ltd. of China.
The recall began after the U.S. FDA announced it had reason to believe some of the Valsartan entering the U.S. had become contaminated with N-nitrosodimethylamine (NDMA), considered a probable human carcinogen. The agency is still investigating, but said the contamination was believed to be related to changes in the way that Valsartan was manufactured. There are allegations in the lawsuits that as early as 2012 distributors ignored clear warning signs regarding the operating standards at the manufacturing plant in China
Valsartan recalls are ongoing, and now plaintiffs’ claims for economic loss are being included in the budding federal blood medication multidistrict litigation recently centralized in New Jersey.
Outreach to Patients Using Valsartan for Hypertension Control
If you have been prescribed valsartan and you were informed by your doctor, or otherwise learned, that your drug was recalled, the fraud and consumer safety lawyers at Lieff Cabraser welcome the chance to talk with you about your case against the manufacturer and distributors of Valsartan. You can contact us using the form below, or by calling us toll-free at 1 800 321-1510. All information will be treated with the highest confidentiality, and there is no charge for our review of your case.